CVRx, Inc.
CVRX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001235912
In the last 90 days, CVRx, Inc. insiders filed 1 open-market purchase and 1 sale; 87 institutions reported holding it in 13F filings for Q2 2026, worth $78.7M in total; no superinvestor holds it.
Holders of 5% or more of CVRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CVRx, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 13G/A | 15.40%4.02M shares | – | Jan 12, 20261 filing | Jan 12, 2026 | SEC |
| New Enterprise Associates 10 L P | 13D/A | 7.80%2.03M shares | – | Feb 20, 20251 filing | Feb 20, 2025 | SEC |
| Vensana Capital I GP, LLC | 13G/A | 7.20%1.76M shares | – | Feb 6, 20251 filing | Feb 6, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on CVRx, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 12, 20267:51 PM ET | Johnson & Johnsonand 1 other | 13G/A | 15.40%4.02M shares | – | Dec 31, 2025 | SEC |
| Feb 20, 20257:08 PM ET | New Enterprise Associates 10 L Pand 7 others | 13D/A | 7.80%2.03M shares | – | Feb 18, 2025 | SEC |
| Feb 6, 20256:49 PM ET | Cooperatieve Gilde Healthcare IV U.A.and 4 others | 13D/A | 4.90%1.23M shares | –Below 5% | Feb 4, 2025 | SEC |
| Feb 6, 20254:46 PM ET | Vensana Capital I GP, LLCand 3 others | 13G/A | 7.20%1.76M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CVRx, Inc. shares.
No Form 144 notices for CVRx, Inc. are on file.